These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small-cell lung cancer. Hao L; Chen H; Wang L; Zhou H; Zhang Z; Han J; Hou J; Zhu Y; Zhang H; Wang Q Thorac Cancer; 2023 Apr; 14(11):1036-1041. PubMed ID: 36810856 [TBL] [Abstract][Full Text] [Related]
12. NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration. Ikematsu Y; Tanaka K; Toyokawa G; Ijichi K; Ando N; Yoneshima Y; Iwama E; Inoue H; Tagawa T; Nakanishi Y; Okamoto I Lung Cancer; 2020 Aug; 146():97-104. PubMed ID: 32526603 [TBL] [Abstract][Full Text] [Related]
13. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. Mollaoglu G; Guthrie MR; Böhm S; Brägelmann J; Can I; Ballieu PM; Marx A; George J; Heinen C; Chalishazar MD; Cheng H; Ireland AS; Denning KE; Mukhopadhyay A; Vahrenkamp JM; Berrett KC; Mosbruger TL; Wang J; Kohan JL; Salama ME; Witt BL; Peifer M; Thomas RK; Gertz J; Johnson JE; Gazdar AF; Wechsler-Reya RJ; Sos ML; Oliver TG Cancer Cell; 2017 Feb; 31(2):270-285. PubMed ID: 28089889 [TBL] [Abstract][Full Text] [Related]
14. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Semenova EA; Nagel R; Berns A Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517 [TBL] [Abstract][Full Text] [Related]
16. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406 [TBL] [Abstract][Full Text] [Related]
17. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131 [TBL] [Abstract][Full Text] [Related]
18. BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation. Chen H; Gesumaria L; Park YK; Oliver TG; Singer DS; Ge K; Schrump DS Mol Cancer Res; 2023 Feb; 21(2):91-101. PubMed ID: 36378541 [TBL] [Abstract][Full Text] [Related]
19. Family matters: How MYC family oncogenes impact small cell lung cancer. Brägelmann J; Böhm S; Guthrie MR; Mollaoglu G; Oliver TG; Sos ML Cell Cycle; 2017 Aug; 16(16):1489-1498. PubMed ID: 28737478 [TBL] [Abstract][Full Text] [Related]
20. Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer. Ciampricotti M; Karakousi T; Richards AL; Quintanal-Villalonga À; Karatza A; Caeser R; Costa EA; Allaj V; Manoj P; Spainhower KB; Kombak FE; Sanchez-Rivera FJ; Jaspers JE; Zavitsanou AM; Maddalo D; Ventura A; Rideout WM; Akama-Garren EH; Jacks T; Donoghue MTA; Sen T; Oliver TG; Poirier JT; Papagiannakopoulos T; Rudin CM Cancer Discov; 2021 Dec; 11(12):3214-3229. PubMed ID: 34344693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]